OGN Earnings & Financial Statements
Organon & Co.
$13.81
+$0.06(+0.44%)
70
Overall
100
Value
75
Tech
36
Quality
Market Cap
$3.63B
Volume
3.26M
52W Range
$5.69 - $13.79
Target Price
$10.50
OGN earnings and financial statements: Organon & Co.'s income statement, balance sheet and cash flow statement, annual and quarterly.
OGN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B |
| Cost of revenue | $2.90B | $2.69B | $2.52B | $2.29B | $2.38B |
| Operating income | $1.23B | $1.41B | $1.33B | $1.71B | $1.81B |
| EBITDA | $1.29B | $1.60B | $1.44B | $1.76B | $1.98B |
| Net income | $187.00M | $864.00M | $1.02B | $917.00M | $1.35B |
| EPS (diluted) | $0.72 | $3.33 | $3.99 | $3.59 | $5.31 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $12.87B | $13.10B | $12.06B | $10.96B | $10.68B |
| Total liabilities | $12.12B | $12.63B | $12.13B | $11.85B | $12.19B |
| Shareholders’ equity | $752.00M | $472.00M | -$70.00M | -$892.00M | -$1.51B |
| Cash and equivalents | $574.00M | $675.00M | $693.00M | $706.00M | $737.00M |
| Long-term debt | $8.63B | $8.86B | $8.75B | $8.90B | $9.13B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $700.00M | $939.00M | $799.00M | $858.00M | $2.46B |
| Capital expenditure | -$285.00M | -$276.00M | -$261.00M | -$427.00M | -$488.00M |
| Free cash flow | $414.00M | $659.00M | $546.00M | $431.00M | $1.97B |
| Dividends paid | $88.00M | $297.00M | $294.00M | $290.00M | $145.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OGN | $13.81 | +0.4% | 3.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |